Literature DB >> 9062779

Prevalence of hepatitis C virus genotypes in southern Italy.

S Cicciarello1, G Borgia, J Crowell, R Ciampi, R Cerini, R Orlando, M Mainolfi, L Reynaud, M Milano, M Piazza.   

Abstract

HCV is ubiquitous. In 50% of all cases it causes chronic hepatitis that often evolves into liver cirrhosis and hepatocellular carcinoma. Recently HCV has been classified in 5 genotypes by Okamoto. The purpose of this study is to evaluate the prevalence of 5 genotypes in Campania, a region of southern Italy, where the prevalence of anti-HCV antibodies ranges from 0.87 to 4%, and to evaluate the correlation between the HCV genotypes and the severity of histological damage. One-hundred- and-thirty-five anti-HCV positive patients were enrolled and tested by PCR to identify HCV-RNA. One-hundred-and-twenty-four patients resulted HCV-RNA positive. Genotyping was performed as described by Okamoto et al. with minor modifications of the specific primer to type III proposed by Silini et al. Eight patients were negative for all genotypes. Eight patients were positive for type I(1a), 61 for type II(1b), 39 for type III(2a), 11 for type IV(2b) and 1 for type V(3a). In 4 cases two different genotypes were present in the same sample [II(1b)-IV(2b), III(2a)-II(1b) twice, III (2a)-IV(2b)]. Histological evaluation of liver damage showed: CPH (22 cases), minimal CAH (56), severe CAH (31) and liver cirrhosis (15). There was no statistically significant correlation between the 5 genotypes and the severity of histological damage. Data on the prevalence of genotype II (1b) in Italy are similar to those reported for other European countries. The prevalence of genotypes in southern Italy is similar to that reported in the population of northern Italy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9062779     DOI: 10.1023/a:1007324300358

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  23 in total

1.  Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups.

Authors:  R H Miller; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

2.  Hepatitis C-associated hepatocellular carcinoma.

Authors:  F Hasan; L J Jeffers; M De Medina; K R Reddy; T Parker; E R Schiff; M Houghton; Q L Choo; G Kuo
Journal:  Hepatology       Date:  1990-09       Impact factor: 17.425

3.  Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease.

Authors:  G Dusheiko; H Schmilovitz-Weiss; D Brown; F McOmish; P L Yap; S Sherlock; N McIntyre; P Simmonds
Journal:  Hepatology       Date:  1994-01       Impact factor: 17.425

Review 4.  Genetic variation of the hepatitis C virus (HCV) genome: random events or a clinically relevant issue?

Authors:  C Bréchot; D Kremsdorf
Journal:  J Hepatol       Date:  1993-03       Impact factor: 25.083

5.  Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease.

Authors:  N Kato; O Yokosuka; K Hosoda; Y Ito; M Ohto; M Omata
Journal:  Hepatology       Date:  1993-07       Impact factor: 17.425

6.  Hepatocellular carcinoma in Italian patients with cirrhosis.

Authors:  M Colombo; R de Franchis; E Del Ninno; A Sangiovanni; C De Fazio; M Tommasini; M F Donato; A Piva; V Di Carlo; N Dioguardi
Journal:  N Engl J Med       Date:  1991-09-05       Impact factor: 91.245

7.  Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection.

Authors:  H Okamoto; H Tokita; M Sakamoto; M Horikita; M Kojima; H Iizuka; S Mishiro
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

8.  Virological features of hepatitis C virus infection in hemodialysis patients.

Authors:  E Silini; F Bono; A Cerino; V Piazza; E Solcia; M U Mondelli
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

9.  Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities.

Authors:  E Silini; F Bono; A Cividini; A Cerino; S Bruno; S Rossi; G Belloni; B Brugnetti; E Civardi; L Salvaneschi
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

10.  Genotypic analysis of hepatitis C virus in American patients.

Authors:  K Mahaney; V Tedeschi; G Maertens; A M Di Bisceglie; J Vergalla; J H Hoofnagle; R Sallie
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

View more
  3 in total

1.  HCV and GBV-c/HGV infection in HIV positive patients in southern Italy.

Authors:  D Rendina; E Vigorita; R Bonavolta; M D'Onofrio; A Iura; M T Pietronigro; R Laccetti; G Bonadies; G Liuzzi; G Borgia; P Formisano; P Laccetti; G Portella
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Epidemiology of hepatitis C virus antibodies in blood donors from the province of Latina, Italy.

Authors:  G La Torre; E De Vito; E Langiano; P Petta; G Colarossi; L Cipriani; M Tucciarone; G Ricciardi
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

3.  The "hidden" epidemic: a snapshot of Moroccan intravenous drug users.

Authors:  Roxana-Delia Trimbitas; Fatima Zahra Serghini; Fatiha Lazaar; Warda Baha; Abderrahim Foullous; Mohammed Essalhi; Abdelouahed El Malki; Abdelkrim Meziane Bellefquih; Abdelouaheb Bennani
Journal:  Virol J       Date:  2014-03-06       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.